Gsa Capital Partners LLP Arca Biopharma, Inc. Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.15 - $2.97 $950,181 - $1.31 Million	-441,945 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.77 - $3.74 $862,993 - $1.17 Million	311,550 Added 238.93%	441,945 $1.31 Million
Q2 2021 Aug 05, 2021	BUY	$3.06 - $3.9 $113,691 - $144,900	37,154 Added 39.85%	130,395 $455,000
Q1 2021 May 10, 2021	BUY	$3.48 - $5.3 $164,061 - $249,863	47,144 Added 102.27%	93,241 $340,000
Q4 2020 Feb 03, 2021	BUY	$3.74 - $5.18 $172,402 - $238,782	46,097 New	46,097 $185,000

280K

Ticker ABIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,410,100
Description
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.